BBZA — BB Biotech AG Cashflow Statement
0.000.00%
Last trade - 00:00- €2.60bn
- €335.04m
- CH₣616.74m
Annual cashflow statement for BB Biotech AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -59.5 | -44.3 | -35.3 | -31.1 | -26.4 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -94.8 | 231 | 218 | 305 | 309 |
| Financing Cash Flow Items | -0.986 | -1.73 | -5.8 | -4.98 | -0.055 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 91.8 | -233 | -220 | -305 | -203 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.98 | -0.887 | -1.45 | -0.043 | 97.8 |